Description
The EA pharmaceutical market is ~$3.4bn expected to grow at 4-6% driven by improving population dynamics, government support, and addressing the growing disease burden – Kenya is the largest market at $1.2bn and expected to grow at 7% Kenya is the most advanced manufacturer of pharma in the region and is also an exporter to the broader EAC In Kenya, government and donors are responsible for ~2/3 of the procurement with KEMSA (government buyer) as the largest buyer.
